PCSK9 has been investigated in neurodegenerative disorders such as Alzheimer’s disease, where altered levels of the protein levels in cerebrospinal fluid (CSF) [17] and brain samples [20] have been associated with disease. The gene discussed is PCSK9; the disease is early-onset autosomal dominant Alzheimer disease.